Table 1

Clinical characteristics of the entire group and those with and without gout at baseline

Clinical featuresAll participants (n=60)Participants without gout (n=48)Participants with gout (n=12)
Age, years46 (8)46 (8)49 (8)
Female sex, n (%)37 (62%)32 (67%)5 (42%)
Ethnicity
 Māori19 (32%)14 (29%)5 (42%)
 Pacific18 (30%)16 (33%)2 (17%)
 European/Other23 (38%)18 (38%)5 (42%)
Diabetes disease duration, years8.3 (5.0)8.0 (5.0)9.3 (4.5)
Diuretic use, n (%)26 (43%)21 (44%)5 (42%)
Weight, kg135.3 (22.1)134 (22)139.8 (23.8)
Body mass index, kg/m247.9 (5.9)47.7 (6.1)48.5 (5.4)
Fasting glucose, mmol/L9.6 (2.9)9.6 (3.1)9.6 (1.9)
HbA1c, %8.1 (1.1)8.2 (1.1)7.9 (0.93)
Triglycerides, mmol/L1.7 (0.8)1.7 (0.9)1.5 (0.4)
Creatinine, μmol/L79 (19)75 (17)94 (20)***
Glomerular filtration rate, mL/min/1.73 m2103 (38)130 (38)96 (34)**
Serum urate, mmol/L0.38 (0.09)0.37 (0.09)0.41 (0.07)
Patients with serum urate above saturation (≥0.41 mmol/L), n (%)24 (40%)19 (40%)5 (42%)
Patients with serum urate above therapeutic target (≥0.36 mmol/L), n (%)35 (58%)25 (52%)10 (83%)*
  • Unless specified, data represented as mean (SD). p Values refer to comparison between participants with and without gout, *p<0.05, **p<0.01, ***p<0.001.